Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
2591 - 2600 of 8808 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSI
    2022
    Summary Details
    RESTRICTED
    Title: Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSI
    Author(s): Jannik Prasuhn, Martin Göttlich, Britt Ebeling, Sofia Kourou, Friederike Gerkan, Christina Bodemann, Sinja S. Großer, Katharina Reuther, Henrike Hanßen, Norbert Brüggemann
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 24
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201288
    Citation Count: 8
  • Association of Early Weight Change With Cognitive Decline in Patients With Parkinson Disease
    2022
    Summary Details
    RESTRICTED
    Title: Association of Early Weight Change With Cognitive Decline in Patients With Parkinson Disease
    Author(s): Ryul Kim, Seo Hee Choi, Kyeongho Byun, Nyeonju Kang, Young Ju Suh, Jin‐Sun Jun, Beomseok Jeon
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 100
    Issue #: 2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201404
    Citation Count: 9
  • Progressive Supranuclear Palsy Syndrome Associated With a Novel Tauopathy
    2022
    Summary Details
    RESTRICTED
    Title: Progressive Supranuclear Palsy Syndrome Associated With a Novel Tauopathy
    Author(s): Shelley L. Forrest, Maria Carmela Tartaglia, Ain Kim, Paula Alcaide‐Leon, Ekaterina Rogaeva, Anthony E. Lang, Gábor G. Kovács
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 24
    Start Page: 1094
    End Page: 1098
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000201485
    Citation Count: 10
  • Quality of Life for Patients With Parkinson Disease
    2022
    Summary Details
    OPEN
    Title: Quality of Life for Patients With Parkinson Disease
    Author(s): Lauren Talman
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 98
    Issue #: 22
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200741
    Citation Count: 3
  • Planning for Prevention of Parkinson Disease
    2022
    Summary Details
    OPEN
    Title: Planning for Prevention of Parkinson Disease
    Author(s): Grace F. Crotty, Jessi L. Keavney, Roy N. Alcalay, Kenneth Marek, Gad A. Marshall, H. Diana Rosas, Michael A. Schwarzschild
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 7_Supplement_1
    Start Page: 1
    End Page: 9
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200789
    Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/1.full.pdf
    Citation Count: 22
  • The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis
    2022
    Summary Details
    OPEN
    Title: The ExTINGUISH Trial: A Phase-2B Randomized Placebo-Controlled Trial of Inebilizumab in Anti-NMDA Receptor Encephalitis
    Author(s): Ka‐Ho Wong, Gregory S. Day, Maarten J. Titulaer, James C. Torner, Merit Cudkowicz, Christopher S. Coffey, Codrin Lungu, Eric C. Klawiter, J. Singleton, Dana Mitchell, Janel Fedler, Dixie Ecklund, David Klements, Michele Costigan, Stacey Clardy
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903316.50895.83
    Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S39.full.pdf
    Citation Count: 3
  • Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)
    2022
    Summary Details
    OPEN
    Title: Safety, Efficacy, And Pharmacokinetics of Argx-117 in Adults With Multifocal Motor Neuropathy: A Global, Multicenter, Placebo Controlled Phase 2 Study (Arda)
    Author(s): Jeffrey Allen, Eduardo Nobile-Orazio, Stojan Perić, Hans Katzberg, Stephanie Cadour, Inge Van de Walle, Iris Van Hoomissen, Bert Jacquemyn, Olivier Van de Steen, W Ludo van der Pol
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903320.23411.f9
    Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S40.full.pdf
    Citation Count: 3
  • What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?
    2022
    Summary Details
    OPEN
    Title: What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?
    Author(s): John Seibyl, Phillip H. Kuo
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 7_Supplement_1
    Start Page: 61
    End Page: 67
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200786
    Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/61.full.pdf
    Citation Count: 18
  • Lifestyle Interventions for the Prevention of Parkinson Disease
    2022
    Summary Details
    OPEN
    Title: Lifestyle Interventions for the Prevention of Parkinson Disease
    Author(s): Jules M. Janssen Daalen, Sabine Schootemeijer, Edo Richard, Sirwan K.L. Darweesh, Bastiaan R. Bloem
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 7_Supplement_1
    Start Page: 42
    End Page: 51
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000200787
    Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/42.full.pdf
    Citation Count: 44
  • An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 Therapies
    2022
    Summary Details
    OPEN
    Title: An Observational Study on the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccination in Multiple Sclerosis and Other Autoimmune Neurological Disorders Treated With Anti-CD20 Therapies
    Author(s): Tyler L. Borko, Sean Selva, Ryan D. Baxter, Berenice Cabrera-Martinez, Cody Rester, Stefan Sillau, Daniel M. Pastula, Maite Sabalza, Iswariya Venkataraman, Eagappanath Thiruppathi, Jeffrey L. Bennett, Enrique Alarcón Álvarez, Robert A. Gross, Anna Shah, Ryan Kammeyer, Timothy R. Vollmer, Ross M. Kedl, John R. Corboy, Elena W.Y. Hsieh, Amanda L. Piquet
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 99
    Issue #: 23_Supplement_2
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/01.wnl.0000903428.98962.0a
    Best OA location URL: https://n.neurology.org/content/neurology/99/23_Supplement_2/S52.full.pdf
    Citation Count: 1
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.